A citation-based method for searching scientific literature

Sylvie Lantuejoul, Daniel Pissaloux, Gilbert R Ferretti, Anne McLeer. Semin Diagn Pathol 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
Lecia V Sequist, Belinda A Waltman, Dora Dias-Santagata, Subba Digumarthy, Alexa B Turke, Panos Fidias, Kristin Bergethon, Alice T Shaw, Scott Gettinger, Arjola K Cosper,[...]. Sci Transl Med 2011
50

Role of Immunocytochemistry in the Cytological Diagnosis of Pulmonary Tumors.
Jasna Metovic, Luisella Righi, Luisa Delsedime, Marco Volante, Mauro Papotti. Acta Cytol 2020
13
50

Expression of insulinoma-associated protein 1 in non-small cell lung cancers: a diagnostic pitfall for neuroendocrine tumors.
Minhua Wang, Rita Abi-Raad, Rebecca Baldassarri, Adebowale J Adeniran, Guoping Cai. Hum Pathol 2021
2
50


Small-cell lung cancer: what we know, what we need to know and the path forward.
Adi F Gazdar, Paul A Bunn, John D Minna. Nat Rev Cancer 2017
60
50

CD44 and OTP are strong prognostic markers for pulmonary carcinoids.
Dorian R A Swarts, Mieke E R Henfling, Leander Van Neste, Robert-Jan van Suylen, Anne-Marie C Dingemans, Winand N M Dinjens, Annick Haesevoets, Martina Rudelius, Erik Thunnissen, Marco Volante,[...]. Clin Cancer Res 2013
51
50

EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer.
Rie Sakakibara, Kentaro Inamura, Yuichi Tambo, Hironori Ninomiya, Satoru Kitazono, Noriko Yanagitani, Atsushi Horiike, Fumiyoshi Ohyanagi, Yosuke Matsuura, Masayuki Nakao,[...]. Clin Lung Cancer 2017
84
50

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee.
Sylvie Lantuejoul, Ming Sound-Tsao, Wendy A Cooper, Nicolas Girard, Fred R Hirsch, Anja C Roden, Fernando Lopez-Rios, Deepali Jain, Teh-Ying Chou, Noriko Motoi,[...]. J Thorac Oncol 2020
133
50

ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs.
Mark D Borromeo, Trisha K Savage, Rahul K Kollipara, Min He, Alexander Augustyn, Jihan K Osborne, Luc Girard, John D Minna, Adi F Gazdar, Melanie H Cobb,[...]. Cell Rep 2016
204
50

The prognostic implications of Notch1, Hes1, Ascl1, and DLL3 protein expression in SCLC patients receiving platinum-based chemotherapy.
Salomon Tendler, Lena Kanter, Rolf Lewensohn, Cristian Ortiz-Villalón, Kristina Viktorsson, Luigi De Petris. PLoS One 2020
7
50

Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer.
Satoshi Hokari, Yusuke Tamura, Atsushi Kaneda, Akihiro Katsura, Masato Morikawa, Fumihiko Murai, Shogo Ehata, Shuichi Tsutsumi, Yuichi Ishikawa, Hiroyuki Aburatani,[...]. Mol Oncol 2020
12
50

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)-from morphology to molecular testing.
Luisella Righi, Francesca Franzi, Francesca Montarolo, Gaia Gatti, Massimo Bongiovanni, Fausto Sessa, Stefano La Rosa. J Thorac Dis 2017
17
50

Targeted disruption of NeuroD, a proneural basic helix-loop-helix factor, impairs distal lung formation and neuroendocrine morphology in the neonatal lung.
Enid R Neptune, Megan Podowski, Carla Calvi, Jang-Hyeon Cho, Joe G N Garcia, Rubin Tuder, R Ilona Linnoila, Ming-Jer Tsai, Harry C Dietz. J Biol Chem 2008
31
50

Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer.
Anna F Farago, Beow Y Yeap, Marcello Stanzione, Yin P Hung, Rebecca S Heist, J Paul Marcoux, Jun Zhong, Deepa Rangachari, David A Barbie, Sarah Phat,[...]. Cancer Discov 2019
94
50

Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.
Bryce Noll, Wei-Lien Wang, Yun Gong, Jun Zhao, Neda Kalhor, Victor Prieto, Gregg Staerkel, Sinchita Roy-Chowdhuri. Cancer Cytopathol 2018
86
50


Programmed death ligand 1 expression in EBUS aspirates of non-small cell lung cancer: Is interpretation affected by type of fixation?
John R Gosney, Alexander Haragan, Claire Chadwick, Tom E Giles, Seamus Grundy, Victoria Tippett, Krishna P Gumparthy, Andrew Wight, Hock G Tan. Cancer Cytopathol 2020
15
50

Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of small cell lung cancer.
Yasushi Murakami, Masahide Oki, Hideo Saka, Chiyoe Kitagawa, Yoshihito Kogure, Misaki Ryuge, Rie Tsuboi, Saori Oka, Masashi Nakahata, Yoriko Funahashi,[...]. Respir Investig 2014
23
50

Basic helix-loop-helix transcription factor profiling of lung tumors shows aberrant expression of the proneural gene atonal homolog 1 (ATOH1, HATH1, MATH1) in neuroendocrine tumors.
B A Westerman, R H J Breuer, A Poutsma, A Chhatta, L A Noorduyn, M G J Koolen, P E Postmus, M A Blankenstein, C B M Oudejans. Int J Biol Markers 2007
12
50

Interobserver variability in diagnosing high-grade neuroendocrine carcinoma of the lung and comparing it with the morphometric analysis.
Seung Yeon Ha, Joungho Han, Wan-Seop Kim, Byung Seong Suh, Mee Sook Roh. Korean J Pathol 2012
19
50

The clinical impact of three validated PD-L1 immunohistochemistry assays as a prognostic factor in small cell lung cancer.
Yong Seok Lee, Jun Hyeok Lim, Wookyung Ryu, Mi Hwa Park, Lucia Kim, Kang Kim, Woo Youl Kim, Hae-Seong Nam. Transl Lung Cancer Res 2021
4
50

Reproducibility of neuroendocrine lung tumor classification.
W D Travis, A A Gal, T V Colby, D S Klimstra, R Falk, M N Koss. Hum Pathol 1998
189
50

Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.
Charles M Rudin, John T Poirier, Lauren Averett Byers, Caroline Dive, Afshin Dowlati, Julie George, John V Heymach, Jane E Johnson, Jonathan M Lehman, David MacPherson,[...]. Nat Rev Cancer 2019
10
50

New Approaches to SCLC Therapy: From the Laboratory to the Clinic.
John T Poirier, Julie George, Taofeek K Owonikoko, Anton Berns, Elisabeth Brambilla, Lauren A Byers, David Carbone, Huanhuan J Chen, Camilla L Christensen, Caroline Dive,[...]. J Thorac Oncol 2020
57
50

hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors.
Bo Ye, Jaclyn Cappel, Jennifer Findeis-Hosey, Loralee McMahon, Qi Yang, Guang-Qian Xiao, Haodong Xu, Faqian Li. Hum Pathol 2016
17
50


34BetaE12 expression along the whole spectrum of neuroendocrine proliferations of the lung, from neuroendocrine cell hyperplasia to small cell carcinoma.
N Sturm, G Rossi, S Lantuéjoul, M-H Laverrière, M Papotti, P-Y Brichon, C Brambilla, E Brambilla. Histopathology 2003
40
50

Clinicopathological Profiling of Lung Carcinoids with a Ki67 Index > 20.
Atsuko Kasajima, Björn Konukiewitz, Naomi Oka, Hiroyoshi Suzuki, Akira Sakurada, Yoshinori Okada, Toru Kameya, Yuichi Ishikawa, Hironobu Sasano, Wilko Weichert,[...]. Neuroendocrinology 2019
30
50

Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability.
Michael A den Bakker, Sten Willemsen, Katrien Grünberg, L Arnold Noorduijn, Matthijs F M van Oosterhout, Robert J van Suylen, Wim Timens, Bart Vrugt, Anne Wiersma-van Tilburg, Frederik B J M Thunnissen. Histopathology 2010
71
50

P40 expression in small cell lung cancer: The presence of p40-positive cells does not always indicate squamous differentiation.
Naoki Nakajima, Akihiko Yoshizawa, Koki Moriyoshi, Makoto Sonobe, Toshi Menju, Shinji Sumiyoshi, Hiroshi Date, Hironori Haga. Thorac Cancer 2019
4
50

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
William D Travis, Elisabeth Brambilla, Andrew G Nicholson, Yasushi Yatabe, John H M Austin, Mary Beth Beasley, Lucian R Chirieac, Sanja Dacic, Edwina Duhig, Douglas B Flieder,[...]. J Thorac Oncol 2015
50

SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas.
Natasha Rekhtman, Joseph Montecalvo, Jason C Chang, Deepu Alex, Ryan N Ptashkin, Ni Ai, Jennifer L Sauter, Brie Kezlarian, Achim Jungbluth, Patrice Desmeules,[...]. J Thorac Oncol 2020
94
50

Clinicopathological characteristics of thyroid transcription factor 1-negative small cell lung cancers.
Yuko Iida, Shinobu Masuda, Yoko Nakanishi, Tetsuo Shimizu, Haruna Nishimaki, Mai Takahashi, Mari Hikichi, Shuichiro Maruoka, Yasuhiro Gon, Noriaki Takahashi,[...]. Hum Pathol 2018
8
50

Targeted Therapies and Biomarkers in Small Cell Lung Cancer.
Hirokazu Taniguchi, Triparna Sen, Charles M Rudin. Front Oncol 2020
35
50

DLL3: an emerging target in small cell lung cancer.
Dwight H Owen, Michael J Giffin, Julie M Bailis, Marie-Anne Damiette Smit, David P Carbone, Kai He. J Hematol Oncol 2019
78
50

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.
Ming Sound Tsao, Keith M Kerr, Mark Kockx, Mary-Beth Beasley, Alain C Borczuk, Johan Botling, Lukas Bubendorf, Lucian Chirieac, Gang Chen, Teh-Ying Chou,[...]. J Thorac Oncol 2018
427
50

Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Natasha Rekhtman, Catherine M Pietanza, Joshua Sabari, Joseph Montecalvo, Hangjun Wang, Omar Habeeb, Kyuichi Kadota, Prasad Adusumilli, Charles M Rudin, Marc Ladanyi,[...]. Mod Pathol 2018
33
50

MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.
Gurkan Mollaoglu, Matthew R Guthrie, Stefanie Böhm, Johannes Brägelmann, Ismail Can, Paul M Ballieu, Annika Marx, Julie George, Christine Heinen, Milind D Chalishazar,[...]. Cancer Cell 2017
246
50

Skn-1a/Pou2f3 functions as a master regulator to generate Trpm5-expressing chemosensory cells in mice.
Junpei Yamashita, Makoto Ohmoto, Tatsuya Yamaguchi, Ichiro Matsumoto, Junji Hirota. PLoS One 2017
59
50

Lung neuroendocrine tumors: pathological characteristics.
Luisella Righi, Gaia Gatti, Marco Volante, Mauro Papotti. J Thorac Dis 2017
17
50

Small-cell lung cancer.
Charles M Rudin, Elisabeth Brambilla, Corinne Faivre-Finn, Julien Sage. Nat Rev Dis Primers 2021
137
50

An achaete-scute homologue essential for neuroendocrine differentiation in the lung.
M Borges, R I Linnoila, H J van de Velde, H Chen, B D Nelkin, M Mabry, S B Baylin, D W Ball. Nature 1997
299
50

Loss of YAP1 defines neuroendocrine differentiation of lung tumors.
Takeshi Ito, Daisuke Matsubara, Ichidai Tanaka, Kanae Makiya, Zen-Ichi Tanei, Yuki Kumagai, Shu-Jen Shiu, Hiroki J Nakaoka, Shumpei Ishikawa, Takayuki Isagawa,[...]. Cancer Sci 2016
50
50

POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer.
Jun Ishii, Hanako Sato, Masashi Sakaeda, Yukiko Shishido-Hara, Chie Hiramatsu, Hiroshi Kamma, Hiroaki Shimoyamada, Masachika Fujiwara, Tetsuya Endo, Ichiro Aoki,[...]. Pathol Int 2013
33
50

New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts.
Sylvie Lantuejoul, Lynnette Fernandez-Cuesta, Francesca Damiola, Nicolas Girard, Anne McLeer. Transl Lung Cancer Res 2020
31
50

The cytomorphologic spectrum of small-cell carcinoma and large-cell neuroendocrine carcinoma in body cavity effusions: A study of 68 cases.
Walid E Khalbuss, Huaitao Yang, Qian Lian, Abdelmonem Elhosseiny, Liron Pantanowitz, Sara E Monaco. Cytojournal 2011
18
50

PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation.
Elena Vigliar, Antonino Iaccarino, Severo Campione, Maria R Campanino, Eduardo Clery, Pasquale Pisapia, Caterina De Luca, Claudio Bellevicine, Umberto Malapelle, Gianfranco De Dominicis,[...]. Diagn Cytopathol 2020
5
50

The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.
Erik Thunnissen, Alain C Borczuk, Douglas B Flieder, Birgit Witte, Mary Beth Beasley, Jin-Haeng Chung, Sanja Dacic, Sylvie Lantuejoul, Prudence A Russell, Michael den Bakker,[...]. J Thorac Oncol 2017
70
50

Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer.
Kosuke Fujino, Yamato Motooka, Wael A Hassan, Mohamed O Ali Abdalla, Yonosuke Sato, Shinji Kudoh, Koki Hasegawa, Kanako Niimori-Kita, Hironori Kobayashi, Ichiro Kubota,[...]. Am J Pathol 2015
90
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.